Three new hires have the discovery moxie Axiom Biotechnologies wants. Michael Kozlowski, COO, was at Bristol-Myers Squibb and Pfizer; Damien Dunnington, VP of discovery research, was at SmithKline Beecham and Aventis; and Steven Brown, director of molecular pharmacology, was with Chugai Biopharmaceuticals.
Hail to the chiefs:
Compugen appointed Vincent Zurawski, from UPenn’s med school, as CEO of its US subsidiary.
Steve Worland moved from Pfizer to CSO at Anadys Pharmaceuticals.
Affy’s new CIO Greg Brandau might not have genomics experience, but the former Pixar Animation exec did oversee production for movies A Bug’s Life and Toy Story 2. Maybe he can get us into sneak previews.
Signature Bioscience’s new CSO is David Spellmeyer from DuPont Pharmaceuticals.
Former Oracle senior veep Joseph Duncan was named chief of oper- ations and IT at UWashington’s Cell Systems Initiative.
Steve Lincoln, who joined InforMax in December, was promoted to CSO.
Princeton University recently appointed its first female president. Taking the helm is Shirley Tilghman, molecular biology professor and director of
the Lewis-Sigler Institute for Integrative Genomics.
Tania Broveak, managing director of genomics tools company Electric Genetics and husband Win Hide, director of the South African National Bioinformatics Institute in Cape Town, announced the April 20 birth of Alexander Jabulani. The baby attended his first Genome Sequencing and Analysis Conference last September in utero.
Viaken Systems beefed up its bioinformatics sales team with Andrew Lambert, vice president of sales worldwide, and Oliver Bayliss, director of European sales. Lambert had been at Cerner, and Bayliss was at Pharmacopeia.
You know you’ve hit the big time when… Not only do Francis Collins and Craig Venter (who recently won a $50,000 Common Wealth Award for science and invention) have to share the limelight at BIO 2001 this month, but they’ll get to speak alongside none other than singer Naomi Judd.
What do you do after co-founding a European proteomics firm? If you’re Williams Ettouati, director of GeneProt, you go where it’s warm: San Diego-based Aurora Biosciences, where he’s now VP of business development.
Joel Bellenson and Dexster Smith, cofounders of DoubleTwist, recently shut down another venture, DigiScents, which tried to transmit smells over the Internet. Now that just stinks.